A+ A A-

Highlights

National Cancer Institute

Tagged under:

Some postmenopausal women with breast cancer may forgo chemotherapy

Some postmenopausal women with HR-positive, HER2-negative breast cancer may not benefit from chemotherapy and can safely forgo the treatment, according to clinical trial results presented at the San Antonio Breast Cancer Symposium.

Study of “exceptional responders” yields clues to cancer and potential treatments

A comprehensive analysis of patients with cancer who had exceptional responses to therapy has revealed molecular changes in the patients’ tumors that may explain some of the exceptional responses.

NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19

NCI and the National Institute of Biomedical Imaging and Bioengineering have awarded seven contracts to develop digital health solutions, like smartphone apps, wearable devices, and software, that help address the COVID-19 pandemic.

NCI, Cancer Research UK launch Cancer Grand Challenges partnership to support bold new ideas for cancer research

NCI and Cancer Research UK will partner to fund Cancer Grand Challenges, an international initiative to address profound and unanswered questions in cancer research.

New treatments spur sharp reduction in lung cancer mortality rate

Mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen sharply in the United States in recent years, due primarily to recent advances in treatment, an NCI study shows.

In primo piano